Subscribe to RSS
DOI: 10.1055/a-2644-0656
Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) for malignant biliary obstruction after failed endoscopic retrograde cholangiography (ERC) in patients with surgically altered anatomy
Endoskopische Ultraschall-geführte biliäre Drainage (EUS-BD) für die maligne Obstruktion nach frustraner endoskopischer retrograder Cholangiographie (ERC) bei Patienten mit chirurgisch-operativ veränderter OberbauchanatomieAuthors
Abstract
Aim
To assess the effectiveness and safety of EUS-BD in patients with jaundice due to malignant biliary obstruction and post-surgically altered anatomy of the upper GI tract who failed prior ERC.
Methods
Over a defined study period, all consecutive patients, who had undergone EUS-BD, were analyzed retrospectively using a computer-based registry.
Results
Overall, 118 patients were registered (mean age, 69 [range, 38–88] years; sex ratio [f:m], 71:47) from 2005–2020. Technical and clinical success rates were 92.4 % and 93.6 %, respectively. 103 self-expandable metallic stents (SEMS), 2 lumen-apposing metal stents (LAMS), and 22 plastic stents were used.
The successful access routes to the bile duct system were trans-gastric (n=69), trans-jejunal (n=39), and trans-esophageal (n=2).
Adverse events (AE) occurred in 19.5 % and re-interventions were necessary in 27.9 % of cases. The median post-interventional survival time was 85 (95% CI: 45–256) days. The following parameters were associated with a significantly shorter survival time: CRP > 50 mg/L, bilirubin serum level > 200 µmol/L, high tumor burden, Karnofsky index < 80, and manifest malnutrition status.
Conclusion
EUS-BD in malignant biliary obstruction is a safe and effective method, even with surgically altered anatomy of the upper GI tract, in experienced hands of interventional EUS.
Zusammenfassung
Ziel
Bestimmung von Effektivität und Sicherheit der EUS-BD bei Patienten mit Ikterus infolge einer malignen biliären Obstruktion und chirurgisch-operativ alterierter Anatomie des oberen GI-Trakts nach gescheiterter ERC.
Methode
Über einen definierten Studienzeitraum wurden alle konsekutiven Patienten, die einer EUS-BD unterzogen worden waren, retrospektiv mittels Computer-basiertem Datenregister analysiert.
Ergebnisse
Insgesamt wurden 118 Patienten dokumentiert (mittleres Alter: 69 [Streubreite: 38–88] Jahre; Sex ratio [f:m]: 71:47) von 2005–2020. Technische und klinische Erfolgsraten lagen bei 92,4 bzw. 93,6 %. 103 selbst-expandierbare Metallstents (SEMS), 2 Lumen-approximierende Metallstents (LAMS) und 22 Plastikstents wurden verwendet.
Die erfolgreich angewandten Zugangswege zum biliären System umfassten: transgastral (n=69), transjejunal (n=39) und transesophageal (n=2).
Nebenwirkungen (AE) traten bei 19,5% auf und Re-interventionen wurden bei 27,9% der Fälle beobachtet. Die mediane postinterventionelle Überlebenszeit betrug 85 (95%-KI: 45–256) d. Die folgenden Parameter waren mit einer signifikant kürzeren Überlebenszeit assoziiert: CRP >50 mg/l, Bilirubin im Serum >200 µmol/l, hohe Tumorlast, Karnofsky-Index <80 und manifester Malnutrition-Status.
Schlussfolgerung
Die EUS-BD stellt bei der malignen biliären Obstruktion in erfahrenen Händen der interventionellen EUS eine sichere und effektive Methode dar, sogar bei chirurgisch-operativ veränderter Anatomie des oberen GI-Trakts.
Keywords
Endoscopic Ultrasonography-Guided Biliary Drainage (EUS-BD) - Malignant biliary obstruction - Endoscopic retrograde cholangiography (ERC) - Percutaneous transhepatic cholangiodrainage (PTCD) - Technical/Clinical success rate - Survival time - Prognostic factorsSchlüsselwörter
Endoskopische Ultraschall-geführte biliäre Drainage (EUS-BD) - maligne biliäre Obstruktion - endoskopische retrograde Cholangiographie (ERC) - perkutane transhepatische Cholangiodrainage (PTCD) - technische/klinische Erfolgsrate - Überlebenszeit - PrognosefaktorenPublication History
Received: 18 October 2024
Accepted after revision: 26 June 2025
Article published online:
08 October 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29
- 2 Esnaola NF, Meyer JE, Karachristos A. et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer 2016; 122: 1349-1369
- 3 Deutsche Krebshilfe Deutsche Krebsgesellschaft, AWMF:, Leitlinienprogramm Onkologie: Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome, Langversion 2.0, 2021, AWMF RegisterPnummer: 032/053OL. 2022 Accessed August 21, 2022 at: https://www.leitlinienprogramm-onkologie.de/leitlinien/hcc-und-billiäre-karzinome
- 4 Venkatachalapathy SV, James MW, Huggett MT. et al. Utility of palliative EUS-guided biliary drainage using lumen-apposing metal stents: a prospective multicenter feasibility study (with video). Gastroint Endosc 2021; 94: 321-328
- 5 Caillol F, Bories E, Zemmour C. et al. Palliative endoscopic drainage of malignant stenosis of biliary confluence: Efficiency of multiple drainage approach to drain a maximum of liver segments. Unit Eur Gastroenterol J 2019; 7: 52-59
- 6 Ullah AA, Rahman A, Chowdhury LH. et al. Improvement of Liver Function, Quality of Life and Survival after Insertion of Endoprosthesis in Advanced Malignant Biliary Obstruction. Mymensingh Med J 2017; 26: 92-103
- 7 Liu Y, Sun J, Ma D. et al. Palliative Locoregional Treatment for Unresectable Nonmetastatic Klatskin Tumor: Percutaneous Transhepatic Biliary Drainage Combined With 3-dimensional Conformal Radiotherapy. J Clin Gastroent 2016; 50: 513-517
- 8 Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002; 56 (06) 835-841
- 9 Rege RV. Adverse effects of biliary obstruction: implications for treatment of patients with obstructive jaundice. Am J Roentgenol 1995; 164 (02) 287-293
- 10 Ballinger AB, McHugh M, Catnach SM. et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994; 35 (04) 467-470
- 11 Dumonceau JM, Tringali A, Papanikolaou IS. et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline–Updated October 2017. Endoscopy 2018; 50 (09) 910-930
- 12 van der Merwe SW, van Wanrooij RLJ, Bronswijk M. et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54 (02) 185-205
- 13 Baniya R, Upadhaya S, Madala S. et al. Endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage after failed endoscopic retrograde cholangiopancreatography: a meta-analysis. Clin Exp Gastroenterol 2017; 10: 67-74
- 14 Nam K, Kim DU, Lee TH. et al. Patient perception and preference of EUS-guided drainage over percutaneous drainage when endoscopic transpapillary biliary drainage fails: An international multicenter survey. Endosc Ultrasound 2018; 7 (01) 48-55
- 15 Teoh AYB, Dhir V, Kida M. et al. Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut 2018; 67 (07) 1209-1228
- 16 Tanisaka Y, Mizuide M, Fujita A. et al. Endoscopic ultrasound-guided biliary drainage in patients with surgically altered anatomy: a systematic review and meta analysis. Scand J Gastroenterol 2023; 58 (02) 107-115
- 17 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71 (03) 446-454
- 18 Sharaiha RZ, Khan MA, Kamal F. et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc 2017; 85 (05) 904-914
- 19 Vanella G, Bronswijk M, Maleux G. et al. EUS-guided intrahepatic biliary drainage: a large retrospective series and subgroup comparison between percutaneous drainage in hilar stenoses or postsurgical anatomy. Endosc Int Open 2020; 8 (12) E1782-E1794
- 20 Wang Y, Lyu Y, Li T. et al. Comparing Outcomes Following Endoscopic Ultrasound-Guided Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Obstruction: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Techn 2022; 32 (07) 747-755
- 21 Nennstiel S, Weber A, Frick G. et al. Drainage-related Complications in Percutaneous Transhepatic Biliary Drainage: An Analysis Over 10 Years. J Clin Gastroenterol 2015; 49 (09) 764-770
- 22 Giurazza F, Corvino F, Contegiacomo A. et al. Safety and effectiveness of ultrasound-guided percutaneous transhepatic biliary drainage: a multicentre experience. J Ultrasound 2019; 22: 437-445
- 23 Khashab MA, El Zein MH, Sharzehi K. et al. EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study. Endosc Int Open 2016; 4 (12) E1322-E1327
- 24 Hayat U, Bakker C, Dirweesh A. et al. EUS-guided versus percutaneous transhepatic cholangiography biliary drainage for obstructed distal malignant biliary strictures in patients who have failed endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis. Endosc Ultrasound 2022; 11 (01) 4-16
- 25 Giri S, Seth V, Afzalpurkar S. et al. Endoscopic Ultrasound-guided Versus Percutaneous Transhepatic Biliary Drainage After Failed ERCP: A Systematic Review and Meta-analysis. Surg Laparosc Endosc Percutan Tech 2023; 33 (04) 411-419
- 26 Ginnaram SR, Nugooru S, Tahir D. et al. Comparative efficacy of endoscopic ultrasound guided biliary drainage versus endoscopic retrograde cholangiopancreatography as first-line palliation in malignant distal biliary obstruction: a systematic review and meta-analysis. Ann Gastroenterol 2024; 37 (05) 602-609
- 27 Khoury T, Sbeit W, Fumex F. et al. Endoscopic ultrasound- versus ERCP-guided primary drainage of inoperable malignant distal biliary obstruction: systematic review and meta-analysis of randomized controlled trials. Endoscopy 2024; 56 (12) 955-963
- 28 Gopakumar H, Singh RR, Revanur V. et al. Endoscopic Ultrasound-Guided vs Endoscopic Retrograde Cholangiopancreatography-Guided Biliary Drainage as Primary Approach to Malignant Distal Biliary Obstruction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol 2024; 119 (08) 1607-1615
- 29 Han Y, Kim SO, So H. et al. EUS-guided biliary drainage versus ERCP for first-line palliation of malignant distal biliary obstruction: A systematic review and meta-analysis. Scient Rep 2019; 9 (01) 16551
- 30 Hathorn KE, Bazarbashi AN, Sack JS. et al. EUS-guided biliary drainage is equivalent to ERCP for primary treatment of malignant distal biliary obstruction: a systematic review and meta-analysis. Endosc Int Open 2019; 7 (11) E1432-E1441
- 31 Kakked G, Salameh H, Cheesman AR. et al. Primary EUS-guided biliary drainage versus ERCP drainage for the management of malignant biliary obstruction: A systematic review and meta-analysis. Endosc Ultrasound 2020; 9 (05) 298-307
- 32 Dhindsa BS, Mashiana HS, Dhaliwal A. et al. EUS-guided biliary drainage: A systematic review and meta-analysis. Endosc Ultrasound 2020; 9 (02) 101-109
- 33 Siripun A, Sripongpun P, Ovartlarnporn B. Endoscopic ultrasound-guided biliary intervention in patients with surgically altered anatomy. World J Gastroenterol 2015; 7 (03) 283-289
- 34 Imai H, Takenaka M, Omoto S. et al. Utility of Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting for Malignant Biliary Obstruction after Failed Endoscopic Retrograde Cholangiopancreatography. Oncology 2017; 93 (Suppl. 01) 69-75
- 35 Nakai Y, Isayama H, Kawakami H. et al. Prospective multicenter study of primary EUS-guided choledochoduodenostomy using a covered metal stent. Endosc Ultrasound 2019; 8 (02) 111-117
- 36 Oh D, Park DH, Song TJ. et al. Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting. Ther Adv Gastroenterol 2017; 10 (01) 42-53
- 37 Zhang Y, Wang X, Sun K. et al. Application of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting in patients with malignant biliary obstruction after failed ERCP. Surg Endosc 2022; 36 (08) 5930-5937
- 38 Nakai Y, Ito Y, Yagioka H. et al. OR-THER-04: Long-term outcomes and reintervention of endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction: A multicenter retrospective analysis of 96 cases. Endoscopic Ultrasound 2017; 6 (Suppl. 01) S8
- 39 Will U, Fueldner F, Kern C. et al. EUS-Guided Bile Duct Drainage (EUBD) in 95 Patients. Ultraschall Med 2015; 36 (03) 276-283
- 40 Kunda R, Perez-Miranda M, Will U. et al. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen-apposing fully covered metal stent after failed ERCP. Surg Endosc 2016; 30 (11) 5002-5008
- 41 Ogura T, Ishiwatari H, Fujimori N. et al. Propensity score matching analysis for adverse events of EUS-guided biliary drainage in advanced elderly patients (PEACE study). Ther Adv Gastroenterol 2022; 15
- 42 Tyberg AB, Napoleon B, Robles-Medranda C. et al. Hepaticogastrostomy versus choledochoduodenostomy: An international multicenter study on their long-term patency. Endosc Ultrasound 2022; 11 (01) 38-43
- 43 Mao K, Hu B, Sun F. et al. Choledochoduodenostomy Versus Hepaticogastrostomy in Endoscopic Ultrasound-guided Drainage for Malignant Biliary Obstruction: A Meta-analysis and Systematic Review. Surg Laparosc Endosc Percut Techniques 2021; 32 (01) 124-132
- 44 Minaga K, Ogura T, Shiomi H. et al. Comparison of the efficacy and safety of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: Multicenter, randomized, clinical trial. Dig Endosc 2019; 31 (05) 575-582
- 45 Nakai Y, Isayama H, Kogure H. et al. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer. J Gastroenterol Hepatol 2014; 29 (09) 1744-1749
- 46 Miyabe K, Hayashi K, Nakazawa T. et al. Safety and benefits of self-expandable metallic stents with chemotherapy for malignant gastric outlet obstruction. Dig Endosc 2015; 27 (05) 572-581
- 47 Paik WH, Woo SM, Chun JW. et al. Efficacy of an internal anchoring plastic stent to prevent migration of a fully covered metal stent in malignant distal biliary strictures: a randomized controlled study. Endoscopy 2021; 53 (06) 578-585
- 48 Hart PC, Rajab IM, Alebraheem M. et al. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol 2020; 11: 95835
- 49 Stocken DD, Hassan AB, Altman DG. et al. Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer 2008; 99 (06) 883-893
- 50 Maltoni M, Pirovano M, Nanni O. et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Sympt Managem 1997; 13 (01) 1-9
- 51 Miura F, Okamoto K, Takada T. et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepato-Biliary-Pancr Scienc 2018; 25 (01) 31-40
- 52 Dixon JM, Armstrong CP, Duffy SW. et al. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983; 24 (09) 845-852
- 53 Wronka KM, Grat M, Stypulkowski J. et al. Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma. J Clin Med 2019; 8 (04) 458
- 54 Mor V, Laliberte L, Morris JN. et al. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53 (09) 2002-2007
- 55 Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980; 45 (08) 2220-2224
- 56 Peus D, Newcomb N, Hofer S. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BioMed Central Medical Informatics and Decision Making 2013; 13 (01) 72
- 57 Abernethy AP, Shelby-James T, Fazekas BS. et al. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BioMed Central Palliative Care 2005; 4 (01) 7
- 58 Jang RW, Caraiscos VB, Swami N. et al. Simple prognostic model for patients with advanced cancer based on performance status. JCO Oncol Pract 2014; 10 (05) e335-e341
- 59 Boeck S, Hinke A, Wilkowski R. et al. Importance of performance status for treatment outcome in advanced pancreatic cancer. World J Gastroenterol 2007; 13 (02) 224-227
- 60 Ryan AM, Power DG, Daly L. et al. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutrit Soc 2016; 75 (02) 199-211
- 61 Zhang X, Tang T, Pang L. et al. Malnutrition and overall survival in older adults with cancer: a systematic review and meta-analysis. J Geriatr Oncol 2019; 10 (06) 874-883
- 62 Kouzu K, Tsujimoto H, Sugasawa H. et al. Impact of postoperative reduced skeletal muscle on prognosis after recurrence in gastric cancer. Mol Clin Oncol 2021; 14 (01) 3
- 63 Sakamoto T, Makinoya M, Sunaguchi T. et al. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer. Plos One 2022; 17 (07) e0271073
- 64 Arends J, Bachmann P, Baracos V. et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017; 36 (01) 11-48
